Taking all together these findings indicate that inhibiting both CD36 and FABP4 induces significant accumulation of unmetabolized lipid, resulting in apoptosis in breast cancer cells and chemical inhibitors of CD36 and FABP4 effectively reduces tumour growth in vivo. Here, FABP4 is linked to breast carcinoma.